Financial highlights
Net earnings
$ per diluted share
Adjusted net earnings1
$ per diluted share
Dividends paid
$ per share of common stock
History of net sales growth $ in billions
Financial overview
 ($ in millions, except per share amounts)
  2017 2016 % Change
Net sales $12,444 $11,325 9.9%
Earnings before income taxes     2,063 1,921 7.4%
Income taxes     1,043 274 280.7%
Net earnings
     1,020 1,647 (38.1)%
Adjusted net earnings1     2,465     2,194 12.3%
       
Net earnings per diluted share of common stock      
   Reported $   2.68 $    4.35  (38.4)%
   Adjusted1      6.49       5.80   11.9%
       
Dividends paid per share of common stock $   1.70 $    1.52   11.8%
Cash, cash equivalents and marketable securities    2,793     3,384  (17.5)%

1. Adjusted net earnings and adjusted net earnings per diluted share are non-GAAP financial measures. See below for a reconciliation to the most directly comparable GAAP financial measures, net earnings and net earnings per diluted share.

Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure
  Net earnings ($ millions)
   Net earnings per diluted share
  2012 2013 2014 2015 2016 2017   2012 2013 2014 2015 2016 2017
Reported $1,298 $1,006 $515 $1,439 $1,647 $1,020   $3.39 $2.63 $1.34 $3.78 $4.35 $2.68
   Acquisition and integration-related charges 37 72 65 24 100 51   0.09 0.19 0.17 0.06 0.26 0.14
   Amortization of purchased intangible assets 88 98 133 147 221 250   0.23 0.26 0.35 0.39 0.59 0.67
   Restructuring-related and other charges 59 46 78 97 98 155   0.15 0.12 0.20 0.26 0.26 0.41
   Rejuvenate and other recall matters 133 460 628 210 127 131   0.35 1.20 1.65 0.55 0.34 0.34
   Regulatory and legal matters 33 63 – (46) (7) 25   0.09 0.17 – (0.12) (0.02) 0.06
   Donations – 15 – – – –   – 0.04 – – – –
   Tax matters – (46) 391 78 8 833   – (0.12) 1.02 0.20 0.02 2.19
Adjusted $1,648 $1,714 $1,810 $1,949 $2,194 $2,465   $4.30 $4.49 $4.73 $5.12 $5.80 $6.49
                           
Effective Tax Rate — Reported 23.9% 17.0% 55.6% 17.1% 14.3% 50.6%              
Effective Tax Rate — Adjusted 24.1% 22.7% 22.3% 17.3% 17.3% 15.6%              
Weighted average diluted shares outstanding               383.0 382.1 382.8 380.9 378.5 380.1

Refer to our 2017 Annual Report on Form 10-K, available at www.stryker.com, for additional information regarding our non-GAAP financial measures.

Leading in medtech
$12.4B in global sales

Global recognition

FORTUNE World’s
Most Admired Companies

#5 in 2018
Medical Products & Equipment
award recipient for the 17th consecutive year

People Companies That Care

#45 in 2017
out of 50 companies — recipient for the first time

Best Workplaces
International

#1 for Australia, 2017
recipient for the fourth consecutive year

Brazil, 2017
recipient for the fourth time

Canada, 2017
recipient for the eighth consecutive year

China, 2017
recipient for the first time

Japan, 2018
recipient for the first time

Mexico, 2017
recipient for the fourth time

Spain, 2017
recipient for the second time

FORTUNE 500 Largest
U.S.-Based Companies

#252 in 2017
joined the list in 2003 as #493
on the list for the 15th consecutive year

LinkedIn Top Companies
Where the World Wants to Work Now

#30 in 2018
recipient for the second time

Fortune Best Workplaces (U.S.)

For Women, 2017
recipient for the first time

For Diversity, 2017
out of 100 companies — recipient for the first time

For Giving Back, 2018
out of 50 companies recognized — recipient for the second consecutive year

FORTUNE World’s Best Workplaces

#10 in 2017
out of 25 companies — recipient for the first time

The Sunday Times 100 Best Companies to Work For

#14 in 2018
Stryker U.K. recipient for the 12th consecutive year

FORTUNE 100 Best
Companies to Work For (U.S.)

#16 in 2018
recipient for the eighth consecutive year

Top Employer Deutschland (Germany)

2018 award
on list for the second consecutive year

Learn more about our business groups:

Sports Medicine

Infrastructure & Integration

Neurovascular